ESR2 and prostate carcinoma: Similarly, other members of the Erb family that are capable of forming heterodimers with EGFR or posttranslational modifications and overexpression of other cell surface receptors, including IGF-1, identified in our proteomics data (Supplemental Table S2) have been shown to play anti-apoptotic roles in prostate cancer [30].